People · Operator

Ghassan S. Kassab

Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology, Other Health Care

2
Companies
3
Filings
$4.5M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Flowco IncBiotechnologySeed$3.0M$82.1M2009
Springboard Medical Innovations, LLCOther Health CareSeed$1.6M$38.4M2010
Operator network

Ghassan S. Kassab at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

David S. Johnson · 3 companies · 1 sharedDavid S. JohnsonFrank S. Wantanabe · 1 companies · 1 sharedFrank S. WantanabeJohn S. Barnard · 1 companies · 1 sharedJohn S. BarnardRobert S. Cathcart · 1 companies · 1 sharedRobert S. CathcartRonald S. Dollens · 1 companies · 1 sharedRonald S. DollensWilliam S. McConnell · 1 companies · 1 sharedWilliam S. McConn…Jennifer L. Rhodes · 2 companies · 2 sharedJennifer L. RhodesJames M. Cornelius · 2 companies · 1 sharedJames M. CorneliusNora S. Doherty · 1 companies · 1 sharedNora S. DohertyRonald M. Dollens · 1 companies · 1 sharedRonald M. DollensWilliam F. McConnell · 1 companies · 1 sharedWilliam F. McConn…Flowco Inc · $3.0M raisedFlowco IncSpringboard Medical Innovations, LLC · $1.6M raisedSpringboard Medical I…Ghassan S. KassabGK
Ghassan S. Kassab Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Ghassan S. Kassab on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jennifer L. Rhodes22
David S. Johnson13
James M. Cornelius12
Ronald M. Dollens11
John S. Barnard11
Ronald S. Dollens11
Frank S. Wantanabe11
William S. McConnell11
Robert S. Cathcart11
William F. McConnell11
Nora S. Doherty11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.